Fundamentally, whether H2Bub1, RNF20, and RNF40 predominantly promote or inhibit carcinoma phenotypes might be influenced by the experimental models chosen or specific cell type and/or disease subtype investigated, and these different roles are probably underpinned by specific transcriptional activators. This evidence concerns the gene RNF40 and carcinoma.